Reducing Opioid Use for Chronic Pain Patients Following Surgery

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity Health Network, Toronto

About this trial

Patients with chronic pain are often prescribed long-term opioid therapy, despite the serious risks and growing concerns related to opioid use. The Toronto General Hospital has created the world's first multidisciplinary perioperative Transitional Pain Service Program (TPSP) aimed at reducing the incidence and severity of chronic post-surgical pain. The TPSP incorporates a variety of mechanisms and interventions to help patients manage pain and to wean off opioids. The approach consists of: pain education, Acceptance and Commitment Therapy (ACT), and an e-mobile self- management tool to help patients manage chronic pain more effectively. With the TPSP team, the investigators hope to continually assist patients to achieve a balance between the benefits and potential harms of opioid use to promote long-term health and well-being.

Eligibility criteria

Qualifiers

≥ 18 years of age

Taking 10 -- 400 mg of preoperative oral morphine equivalents daily

Any type of surgical procedure, with the exception of those with palliative intent or organ transplantation

Able to read and understand English as posed on the questionnaire surveys prior to informed consent

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Interventional Group
  • Control Intervention

Treatment groups

210 Participants
are divided into 2 treatment groups